88 related articles for article (PubMed ID: 20090538)
1. Critical care of HIV-infected patients: still a dilemma for Italian intensivists--results of a multicentre survey.
Corona A; Raimondi F
Eur J Anaesthesiol; 2010 Apr; 27(4):377-82. PubMed ID: 20090538
[TBL] [Abstract][Full Text] [Related]
2. Critical care of HIV infected patients in the highly active antiretroviral therapy era.
Corona A; Raimondi F
Minerva Anestesiol; 2007 Dec; 73(12):635-45. PubMed ID: 18046294
[TBL] [Abstract][Full Text] [Related]
3. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
[TBL] [Abstract][Full Text] [Related]
4. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy.
Adlakha A; Pavlou M; Walker DA; Copas AJ; Dufty N; Batson S; Edwards SG; Singer M; Miller RF
Int J STD AIDS; 2011 Sep; 22(9):498-504. PubMed ID: 21890545
[TBL] [Abstract][Full Text] [Related]
5. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Khouli H; Afrasiabi A; Shibli M; Hajal R; Barrett CR; Homel P
J Intensive Care Med; 2005; 20(6):327-33. PubMed ID: 16280405
[TBL] [Abstract][Full Text] [Related]
6. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
[TBL] [Abstract][Full Text] [Related]
7. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
8. A shift in referral patterns for HIV/AIDS patients.
Fournier PO; Savageau JA; Baldor RA
J Fam Pract; 2008 Feb; 57(2):E1-9. PubMed ID: 18248723
[TBL] [Abstract][Full Text] [Related]
9. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
10. Physician specialization and the quality of care for human immunodeficiency virus infection.
Landon BE; Wilson IB; McInnes K; Landrum MB; Hirschhorn LR; Marsden PV; Cleary PD
Arch Intern Med; 2005 May; 165(10):1133-9. PubMed ID: 15911726
[TBL] [Abstract][Full Text] [Related]
11. [Antiretroviral therapy in critically ill patients: a French national study].
Dinh A; Salomon J; Vuagnat A; De Truchis P; Maury E; Bernard L
Med Mal Infect; 2007 Dec; 37(12):809-15. PubMed ID: 17628372
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenia, AIDS and the decision to prescribe HAART: results of a national survey of HIV clinicians.
Himelhoch S; Powe NR; Breakey W; Gebo KA
J Prev Interv Community; 2007; 33(1-2):109-20. PubMed ID: 17298934
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment].
Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G
Sante; 1999; 9(5):293-300. PubMed ID: 10657773
[TBL] [Abstract][Full Text] [Related]
14. Nonconsented human immunodeficiency virus testing among critically ill patients: intensivists' practices and the influence of state laws.
Halpern SD; Metkus TS; Fuchs BD; Ward NS; Siegel MD; Luce JM; Curtis JR
Arch Intern Med; 2007 Nov; 167(21):2323-8. PubMed ID: 18039991
[TBL] [Abstract][Full Text] [Related]
15. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
16. The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow.
Fox R; Gourlay YJ
Health Bull (Edinb); 2000 Jul; 58(4):309-15. PubMed ID: 12813810
[TBL] [Abstract][Full Text] [Related]
17. The organization of intensive care unit physician services.
Pronovost PJ; Thompson DA; Holzmueller CG; Dorman T; Morlock LL
Crit Care Med; 2007 Oct; 35(10):2256-61. PubMed ID: 17717492
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort.
de Boer-van der Kolk IM; Sprangers MA; Prins JM; Smit C; de Wolf F; Nieuwkerk PT
Clin Infect Dis; 2010 Jan; 50(2):255-63. PubMed ID: 20014949
[TBL] [Abstract][Full Text] [Related]
19. [Admissions of patients with AIDS to pediatric intensive care units].
Casanova Román M; Ríos Hurtado J; García Martín FJ; Milano Manso G; Martínez Valverde A
An Esp Pediatr; 2000 Jun; 52(6):537-41. PubMed ID: 11003962
[TBL] [Abstract][Full Text] [Related]
20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
